Related references
Note: Only part of the references are listed.B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients
Wannarat Pongpirul et al.
NEPHROLOGY (2018)
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
Eileen Samy et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2017)
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients
Olivier Aubert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies
Mark Haas et al.
KIDNEY INTERNATIONAL (2017)
B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation
A. Schuster et al.
TRANSPLANT IMMUNOLOGY (2017)
C1q binding is not an independent risk factor for kidney allograft loss after an acute antibodymediated rejection episode: a retrospective cohort study
Anissa Moktefi et al.
TRANSPLANT INTERNATIONAL (2017)
Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection
Carrie L. Butler et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation
B. J. Orandi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury
Carmen Lefaucheur et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation
M. A. Mujtaba et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft
Antonij Slavcev et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients
Ji Won Min et al.
PLOS ONE (2016)
Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjogren's syndrome
Nicolyn Thompson et al.
RHEUMATOLOGY (2016)
B-Cell-Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney Transplantation
C. Sango et al.
TRANSPLANTATION PROCEEDINGS (2016)
Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
J. Irure et al.
TRANSPLANTATION PROCEEDINGS (2016)
Neutralizing BAFF/APRIL With Atacicept Prevents Early DSA Formation and AMR Development in T Cell Depletion Induced Nonhuman Primate AMR Model
J. Kwun et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction
Anja M. Lehnhardt et al.
CLINICAL TRANSPLANTATION (2015)
BAFF receptors and ligands create independent homeostatic niches for B cell subsets
Martin S. Naradikian et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies
Takahito Niikura et al.
NEPHROLOGY (2015)
Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection
Takahiro Tsuji et al.
NEPHROLOGY (2015)
Monitoring B cell subsets and alloreactivity in kidney transplantation
Marta Crespo et al.
TRANSPLANTATION REVIEWS (2015)
BAFF and Associated TNF Superfamily Members in Renal Transplantation: An End to BLySful Ignorance
Manu Chhabra et al.
TRANSPLANTATION (2013)
Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
Gemma Banham et al.
TRANSPLANTATION (2013)
BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies
A. Thibault-Espitia et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
M. Mengel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Elevated serum levels of B-cell activating factor in pediatric renal transplant patients
Anja Lehnhardt et al.
PEDIATRIC NEPHROLOGY (2012)
Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development
Vassilia-Ismini Alexaki et al.
JOURNAL OF IMMUNOLOGY (2009)
C4d Deposition without Rejection Correlates with Reduced Early Scarring in ABO-Incompatible Renal Allografts
Mark Haas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection
H. Xu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant Recipients
H. Xu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Banff 07 classification of renal allograft pathology: Updates and future directions
K. Solez et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
The Abnormal High Expression of B Cell Activating Factor Belonging to TNF Superfamily (BAFF) and Its Potential Role in Kidney Transplant Recipients
Haiyan Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy
Olivier Thaunat et al.
TRANSPLANTATION (2008)
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACl-Fc treatment in patients with multiple myeloma
M. Abe et al.
LEUKEMIA (2006)
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
Marc Ittah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Share Paper
